| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 93 |
| 1 | OMEPRAZOLE MAGNESIUM | 78 |
| 2 | GABAPENTIN | 74 |
| 3 | ASPIRIN | 65 |
| 4 | ASPIRIN 325 MG | 63 |
| 5 | ASPIRIN 81 MG | 63 |
| 6 | OMEPRAZOLE | 63 |
| 7 | SODIUM OXYBATE | 58 |
| 8 | ACETAMINOPHEN | 56 |
| 9 | NATALIZUMAB | 55 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEXAGLIFLOZIN | 1 | 0.0323 |
| 1 | FERRIC OXIDE RED, ZINC OXIDE, AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0152 |
| 2 | SCOPOLAMINE | 38 | 0.0103 |
| 3 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 1 | 0.0102 |
| 4 | IOBENGUANE I-123 | 1 | 0.0088 |
| 5 | SCOPOLAMINE TRANSDERMAL SYSTEM | 2 | 0.0075 |
| 6 | HISTAMINE | 1 | 0.0069 |
| 7 | ESTRADIOL VALERATE AND ESTRADIOL VALERATE/DIENOGEST | 2 | 0.0062 |
| 8 | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | 1 | 0.0055 |
| 9 | CAMPHOR, EUCALYPTUS OIL, MENTHOL | 1 | 0.0043 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 167 |
| 1 | Benzodiazepine [EPC] | 143 |
| 2 | Corticosteroid [EPC] | 119 |
| 3 | Provitamin D2 Compound [EPC] | 93 |
| 4 | Proton Pump Inhibitor [EPC] | 86 |
| 5 | Vitamin C [EPC] | 84 |
| 6 | GLP-1 Receptor Agonist [EPC] | 74 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 67 |
| 8 | Integrin Receptor Antagonist [EPC] | 64 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 61 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | APOC-III-directed RNA Interaction [EPC] | 1 | 0.0096 |
| 1 | Small Interfering RNA [EPC] | 1 | 0.0063 |
| 2 | Provitamin D2 Compound [EPC] | 93 | 0.0031 |
| 3 | Anticholinergic [EPC] | 42 | 0.0026 |
| 4 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 5 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 6 | Quinolone Antimicrobial [EPC] | 13 | 0.0013 |
| 7 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 5 | 0.0013 |
| 8 | Interferon alfa-2b [EPC] | 2 | 0.0011 |
| 9 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 7 | 0.0010 |